artificial knee replacement
Conditions
Interventions
Brown Splint under development are used
Use commercially available Brown Splint
Sponsors
FUJITA HEALTH UNIVERSITY HOSPITAL
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: free and voluntary written consent can be confirmed
Exclusion criteria
Exclusion criteria: Patients unable to communicate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Relationship between the subject's body size and Brown Splint | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison between "conventional product group" and "developed product group The rate of swelling Difference in pressure on the ground surface of the base Differences in the location of pain and pain evaluation scale Differences in the rate and location of skin redness Differences in post-use impressions | — |
Countries
Japan
Contacts
Public ContactAkiko Watanabe
FUJITA HEALTH UNIVERSITY Center for Collaboration in Research and Innovation
Outcome results
None listed